CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager™ DSLT, the ...

Please provide your email address to receive an email when new articles are posted on . The safety and efficacy of selective laser trabeculoplasty was comparable to argon laser trabeculoplasty. Data ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the Eagle device for selective laser trabeculoplasty. Laser energy is delivered in a noncontact ...

SLT is emerging as a cost-effective first-line treatment, offering superior intraocular pressure stability compared to traditional eye drops. Minimally invasive glaucoma surgeries, like the iStent ...

Nate Lighthizer, OD, FAAO, discusses laser therapy and how attendees at Southeastern Educational Congress of Optometry (SECO) 2025 got hands-on experience at the conference. Laser therapy has been ...

Alcon has announced the US release of its Voyager direct selective laser trabeculoplasty (DSLT) platform, with a launch event scheduled for the American Glaucoma Society annual meeting later in ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient ...

Alcon has bought up Belkin Vision and its laser device for treating glaucoma. The deal includes an upfront transfer of $81 million, including about $65 million in cash—plus the opportunity for up to ...

The CDC reports that over three million Americans have glaucoma. The number may reach 6.3 million by 2050 as the aging population grows. Glaucoma is affecting so many lives, so it’s important to know ...